XML 48 R34.htm IDEA: XBRL DOCUMENT v3.24.3
SHARE-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of the components and classification of share-based compensation expense
The following table summarizes the components and classification of the Company’s share-based compensation expenses related to stock options and RSUs for the three and nine months ended September 30, 2024 and 2023:
Three Months Ended September 30,Nine Months Ended
September 30,
(in millions)2024202320242023
Stock options$$$10 $14 
RSUs 34 25 97 89 
$38 $29 $107 $103 
Research and development expenses$$$$
Selling, general and administrative expenses34 26 98 95 
$38 $29 $107 $103 
Summary of share-based awards
Share-based awards granted for the nine months ended September 30, 2024 and 2023 consist of:
Nine Months Ended
September 30,
20242023
Bausch Health Share-Based Awards
Stock options
Granted— 999,000 
Weighted-average exercise price$— $9.25 
Weighted-average grant date fair value$— $4.87 
Time-based RSUs
Granted5,173,000 4,881,000 
Weighted-average grant date fair value$8.91 $9.02 
Adjusted Operating Cash Flow performance-based RSUs
Granted1,332,000 647,000 
Weighted-average grant date fair value$9.60 $10.57 
Bausch+ Lomb Share-Based Awards
Stock options
Granted1,317,000 3,453,000 
Weighted-average exercise price$16.85 $18.21 
Weighted-average grant date fair value$4.92 $5.33 
RSUs
Granted3,652,000 3,165,000 
Weighted-average grant date fair value$16.77 $17.97 
TSR performance-based RSUs
Granted826,000 1,175,000 
Weighted-average grant date fair value$21.21 $27.65 
Organic Revenue Growth PSUs
Granted379,000 142,000 
Weighted-average grant date fair value$16.08 $17.96 
OPG PSUs
Granted1,792,000 — 
Weighted-average grant date fair value$17.03 $—